BioRestorative Therapies said Lance Alstodt and Robert Kristal resigned from their officer roles effective July 13, 2026, and the board appointed director Katharyn Field as interim Chief Executive Officer, President and interim Chief Financial Officer effective the same date.
| IndividualLance AlstodtRobert KristalKatharyn FieldDavid RosaEsha RandhawaSteven Brown | RolePresident, Chief Executive Officer and Chairman of the BoardChief Financial OfficerChief Executive Officer, President; interim Chief Financial Officer, Treasurer and SecretaryDirectorClass II DirectorClass III Director | Type of ChangeResignedResignedAppointedResignedElectedElected | Effective DateJuly 13, 2026July 13, 2026July 13, 2026July 11, 2026July 13, 2026July 14, 2026 | ReasonResignation notice asserted "Good Reason" based on alleged Change in Control (clause (ii)); filing notes executives requested release for severanceResignation notice asserted "Good Reason" based on alleged Change in Control (clause (ii)); filing notes executives requested release for severanceBoard appointment; no arrangement with other persons; compensation to be disclosed laterResignation notice stated no reason; not aware of disagreement with companyNot disclosedNot disclosed | Replacement InfoKatharyn Field appointed as CEO/President and interim CFO (per board)Interim CFO role filled by Katharyn Field pending search for permanent CFOServing as principal executive officer and interim principal financial/accounting officer; board to search for permanent CFOVacancy filled by election of Esha RandhawaFilled vacancy created by Rosa; term expires at 2028 annual meetingFilled vacancy created by Alstodt's cessation as director; term expires at 2026 annual meeting | Background DetailsNot disclosed in Item 5.02Not disclosed in Item 5.02CEO of iSpecimen; prior roles include President/Chair at iSpecimen, CEO/Chair at Halo Collective, Executive Director at Akanda; MBA Columbia, BA StanfordNot disclosedRegistered Pharmacist; hospital pharmacist since 2022; prior pharmacy management; BSc Pharmaceutical Sciences & Biology; appointed Audit Committee member and Chair of Nominating & Corporate GovernanceChannel Manager, North America at Boyum IT Solutions; strategic advisor; prior roles at Sana Commerce; appointed to Compensation and Nominating & Corporate Governance Committees | Board/Committee Role ChangesCeased serving as director upon resignationCeased serving as officer/director upon resignationCeased to be an independent director; ceased committee service including Chair of Nominating & Corporate GovernanceResigned from Board and committees including Compensation CommitteeAppointed to Audit Committee and Chair of Nominating & Corporate Governance CommitteeAppointed to Compensation Committee and Nominating & Corporate Governance Committee |
Original SEC Filing:
This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.